Geode Capital Management’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,352,580
| Closed | -$200M | – | 4343 |
|
|
2020
Q3 | $200M | Sell |
2,352,580
-149,602
| -6% | -$7.57M | 0.04% | 404 |
|
|
2020
Q2 | $88.7M | Sell |
2,502,182
-271,053
| -10% | -$7.92M | 0.02% | 612 |
|
|
2020
Q1 | $37.4M | Buy |
2,773,235
+232,241
| +9% | +$3.91M | 0.01% | 920 |
|
|
2019
Q4 | $53.8M | Buy |
2,540,994
+220,086
| +9% | +$3.88M | 0.01% | 900 |
|
|
2019
Q3 | $30.8M | Buy |
2,320,908
+19,064
| +0.8% | +$280K | 0.01% | 1187 |
|
|
2019
Q2 | $31.9M | Buy |
2,301,844
+257,713
| +13% | +$3.88M | 0.01% | 1159 |
|
|
2019
Q1 | $39.3M | Buy |
2,044,131
+173,564
| +9% | +$2.8M | 0.01% | 965 |
|
|
2018
Q4 | $26.7M | Buy |
1,870,567
+219,461
| +13% | +$4.36M | 0.01% | 1077 |
|
|
2018
Q3 | $34.4M | Buy |
1,651,106
+94,795
| +6% | +$2.25M | 0.01% | 1034 |
|
|
2018
Q2 | $36.8M | Buy |
1,556,311
+510,544
| +49% | +$10.3M | 0.01% | 941 |
|
|
2018
Q1 | $15.3M | Buy |
1,045,767
+49,434
| +5% | +$808K | 0.01% | 1456 |
|
|
2017
Q4 | $16.1M | Buy |
996,333
+84,407
| +9% | +$996K | 0.01% | 1431 |
|
|
2017
Q3 | $12.7M | Buy |
911,926
+44,913
| +5% | +$448K | ﹤0.01% | 1542 |
|
|
2017
Q2 | $7.66M | Buy |
867,013
+63,288
| +8% | +$444K | ﹤0.01% | 1843 |
|
|
2017
Q1 | $5.2M | Buy |
803,725
+97,640
| +14% | +$495K | ﹤0.01% | 2082 |
|
|
2016
Q4 | $2.59M | Buy |
706,085
+82,947
| +13% | +$245K | ﹤0.01% | 2479 |
|
|
2016
Q3 | $2.02M | Buy |
623,138
+9,105
| +1% | +$25.5K | ﹤0.01% | 2555 |
|
|
2016
Q2 | $1.42M | Buy |
614,033
+43,711
| +8% | +$146K | ﹤0.01% | 2707 |
|
|
2016
Q1 | $1.43K | Buy |
570,322
+7,572
| +1% | +$17K | ﹤0.01% | 2679 |
|
|
2015
Q4 | $1.73M | Buy |
562,750
+12,122
| +2% | +$33.8K | ﹤0.01% | 2574 |
|
|
2015
Q3 | $947K | Buy |
550,628
+4,107
| +0.8% | +$10.5K | ﹤0.01% | 2902 |
|
|
2015
Q2 | $2.22M | Buy |
546,521
+12,411
| +2% | +$50.7K | ﹤0.01% | 2433 |
|
|
2015
Q1 | $2.04M | Buy |
534,110
+6,774
| +1% | +$29.5K | ﹤0.01% | 2427 |
|
|
2014
Q4 | $2.53M | Buy |
527,336
+744
| +0.1% | +$2.94K | ﹤0.01% | 2276 |
|
|
2014
Q3 | $1.96M | Buy |
526,592
+71,113
| +16% | +$240K | ﹤0.01% | 2370 |
|
|
2014
Q2 | $1.66M | Buy |
455,479
+35,178
| +8% | +$129K | ﹤0.01% | 2494 |
|
|
2014
Q1 | $1.77M | Buy |
420,301
+59,258
| +16% | +$294K | ﹤0.01% | 2409 |
|
|
2013
Q4 | $1.66M | Buy |
361,043
+31,705
| +10% | +$141K | ﹤0.01% | 2411 |
|
|
2013
Q3 | $2.04M | Buy |
329,338
+30,753
| +10% | +$177K | ﹤0.01% | 2158 |
|
|
2013
Q2 | $1.62M | Buy |
+298,585
| New | +$981K | ﹤0.01% | 2162 |
|
Geode Capital Management's IMMU Position: Q4 2020 in Review
Geode Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,352,580 shares — an estimated $200M sold.
Geode Capital Management first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $200M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Geode Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Geode Capital Management sold 2,352,580 Immunomedics Inc shares in Q4 2020, an estimated $200M.
- Geode Capital Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Geode Capital Management's Immunomedics Inc position peaked at $200M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.